CureVac N.V. CVAC 深 滬
等待開盤 08-06 09:30:00 美东时间
5.475
+0.015
+0.27%
華盛通- 最 高5.495
- 今 開5.47
- 成交量 35.73万股
- 最 低 5.45
- 昨 收 5.46
- 總市值 12.32亿
- 52周最高 5.72
- 市盈率 靜 7.00
- 換手率 0.16%
- 52周最低 2.37
- 委 比 -16.25%
- 總股本 2.25亿
- 歷史最高 151.80
- 量 比 0.55
- 振 幅 0.82%
- 歷史最低 2.215
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance.
08-04 22:32
BioNTech posts Q2 beat as revenue more than doubles
BioNTech (NASDAQ:BNTX) ADRs added ~2% in the premarket on Monday after the German vaccine maker exceeded Street forecasts with its Q2 2025 financials, thanks mainly to an over two-fold rise in its rev...
08-04 19:38
BioNTech GAAP EPS of -€1.60, revenue of €260.8M
BioNTech press release (NASDAQ:BNTX): Q2 GAAP EPS of -€1.60. Revenue of €260.8M (+102.6% Y/Y). Revenues for the 2025 financial year €1,700 million - €2,200 million More on BioNTech BioNTech: More Unce...
08-04 18:47
BioNTech chief strategy officer resigning
BioNTech (NASDAQ:BNTX) Chief Strategy Officer Ryan Richardson will leave that position on Sept. 30 to pursue another opportunity. He will also resign as a board member of BioNTech affiliated companies...
07-17 23:40
Bird flu emergency response ends as cases decline, CDC says
Citing a drop in case numbers, the Centers for Disease Control and Prevention (CDC) has ended its emergency response to the H5N1 bird flu outbreak, which has affected hundreds of millions of birds and...
07-08 19:10
Abacus Global Management Sues Coventry and its Chairman Alan Buerger for Defamation and Anticompetitive Conduct
Abacus Global Management has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger, alleging a years-long campaign to spread false and misleading information about Abacus, causing reputational and financial harm. The lawsuit claims that Coventry employed short seller Morpheus Research to amplify defamatory statements, leading to a 21% drop in Abacus’s stock price and $200 million in market capitalization loss. Abacus accuses Co...
07-01 20:10
美股大行评级 | 潜在涨幅61.27%！Loop Capital上调英伟达目标价至250美元，维持"买入"评级
今日重点评级关注：Benchmark：维持特斯拉(TSLA)"买入"评级，目标价从350美元升至475美元>>
06-27 08:37
UBS Downgrades CureVac to Neutral, Lowers Price Target to $5.5
UBS analyst Eliana Merle downgrades CureVac (NASDAQ:CVAC) from Buy to Neutral and lowers the price target from $12 to $5.5.
06-26 23:26
Will the Strait of Hormuz Remain at Risk Despite the Iran–Israel Ceasefire?
TradingKey - On June 24, U.S. President Donald Trump announced a "temporary ceasefire" between the U.S. and Iran. However, Iran has not fully endorsed the agreement’s validity.
06-25 10:46
